ArisGlobal’s “2021 State of the Industry Report” Explores Automation Adoption
Report reveals how life sciences companies currently use automation and ...
Report reveals how life sciences companies currently use automation and ...
Innovative R&D company selects LifeSphere by ArisGlobal to further develop ...
ArisGlobal's LifeSphere clinical and regulatory product leader will host a ...
The life sciences R&D technology leader will lead keynote sessions ...
Miami, Florida, Tokyo, August 23, 2021 Asahi Kasei Pharma Corp. ...
ArisGlobal LifeSphere IDMP Requirements, Readiness and Capabilities Acknowledged in Gens ...
ArisGlobal recognized by Frost & Sullivan for enabling life sciences ...
Life sciences leader announces virtual conference to spotlight trends that ...
Fast-growing CRO uses the only automated, end-to-end safety system to ...
As a leading healthcare and technology investor and committed owner, ...
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 500 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2024 ArisGlobal – All Rights Reserved